Atrial arrhythmia. Atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients in sinus rythm and undergoing for openchest surgery. Male and female patients over 18 years old. Patients with paroxysmal AF and undergoing for openchest surgery. Patients with persistent AF and undergoing for openchest surgery. Patients who have given written consent.
Exclusion criteria
Exclusion criteria: Patients who are scheduled for re-operation. Male and female patients under 18 years old. Patients who do not speak/understand Dutch. Patients who are not will-competent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: 1/. To identify new cellular proarrhythmic mechanisms. 2/. To identify new nuclear targets for therapy (i.e. important factors involved in Ca2+-dependent transcription pathways). | — |
Secondary
| Measure | Time frame |
|---|---|
| The knowledge of the cellular mechanisms activated during persistent AF will significantly enhance the chances of better treatment to not only cardioconvert AF, but also to allow the atrial cells to recuperate their function after AF. This is expected to reduce the thromboembolic risks and improve cardiac function after cardioversion of AF. | — |
Countries
Netherlands